Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Contract Services Ride High As Funding Floods Biopharma

Sep 1, 2014

The contract services industry?s success is largely a result of the improved financial environment, rather than an increased acceptance of outsourcing.

When Payers Refuse to Cover New Drugs, CMOs Take a Hit

More health systems are saying no to reimbursements for new drugs; CMOs must adjust strategies.
Aug 4, 2014

More health systems are saying ?no? to reimbursements for new drugs; CMOs must adjust strategies.

Positive Outlook for Outsourcing

Contract services ride high as funding floods bio/pharma.
Aug 1, 2014

Contract services ride high as funding floods bio/pharma.

Health Systems Raise the Bar on Reimbursing New Drugs

As payers refuse to cover new drugs, CMOs take a hit.
Jul 2, 2014

As payers refuse to cover new drugs, CMOs take a hit.

Are CMOs Out of Synch With Market Realities?

Why can't the CMO industry break through to manufacture a greater share of drugs?
May 30, 2014

Why can't the CMO industry break through to manufacture a greater share of drugs?

Stuck in Neutral

The CMO industry's value proposition is limiting its market penetration.
May 2, 2014

The CMO industry's value proposition is limiting its market penetration.

How Will CMO Ownership Changes Impact Market?

Changes in company ownership shake up the CMO industry.
Apr 1, 2014

Changes in company ownership shake up the CMO industry.

Under New Ownership

Changes in company ownership shake up the CMO industry.
Mar 2, 2014

Changes in company ownership shake up the CMO industry.

Evolving R&D Model Pressures Contract Services Market

The R&D model is in transition and creating new demands on contract services providers.
Jan 31, 2014

The R&D model is in transition and creating new demands on contract services providers.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here